Weiping Zou
Affiliations: | University of Michigan, Ann Arbor, Ann Arbor, MI |
Area:
Immunology, Cell Biology, Molecular BiologyGoogle:
"Weiping Zou"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Bao Y, Qiao Y, Choi JE, et al. (2023) Targeting the lipid kinase PIKfyve upregulates surface expression of MHC class I to augment cancer immunotherapy. Proceedings of the National Academy of Sciences of the United States of America. 120: e2314416120 |
Zou W, Green DR. (2023) Beggars banquet: Metabolism in the tumor immune microenvironment and cancer therapy. Cell Metabolism |
Li G, Choi JE, Kryczek I, et al. (2023) Intersection of immune and oncometabolic pathways drives cancer hyperprogression during immunotherapy. Cancer Cell |
Son S, Nam J, Kim AS, et al. (2022) Induction of T-helper-17-cell-mediated anti-tumour immunity by pathogen-mimicking polymer nanoparticles. Nature Biomedical Engineering |
Hong HS, Mbah NE, Shan M, et al. (2022) OXPHOS promotes apoptotic resistance and cellular persistence in T17 cells in the periphery and tumor microenvironment. Science Immunology. 7: eabm8182 |
Sun D, Wang W, Guo F, et al. (2022) DOT1L affects colorectal carcinogenesis via altering T cell subsets and oncogenic pathway. Oncoimmunology. 11: 2052640 |
Liao P, Wang W, Wang W, et al. (2022) CD8 T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. Cancer Cell |
Holcomb EA, Zou W. (2022) A forced marriage of IL-2 and PD-1 antibody nurtures tumor-infiltrating T cells. The Journal of Clinical Investigation. 132 |
Zou W. (2021) Immune regulation in the tumor microenvironment and its relevance in cancer therapy. Cellular & Molecular Immunology. 19: 1-2 |
Qiao Y, Choi JE, Tien JC, et al. (2021) Autophagy Inhibition by Targeting PIKfyve Potentiates Response to Immune Checkpoint Blockade in Prostate Cancer. Nature Cancer. 2: 978-993 |